AKR7A2 and melanoma: In melanoma cells it has been demonstrated that in hypoxic conditions, EV exhibit a miRNome and proteome signature (AKR7A2, DDX39B, EIF3C, FARSA, PRMT5, VARS), which is associated with poor prognosis for the patients [99].